Change in the number of votes relating to Biotie Therapies Corp.'s shares
Biotie Therapies Corp. (“Biotie” or the “Company”) has conveyed Biotie shares held as treasury shares, that were issued on 17 December 2014, pursuant to the Stock Option Plan 2011 (the “Plan”) as follows:
Shares conveyed 388,750
Cumulative shares
conveyed since 17
December 2014
2,209,875
Remaining shares to
be conveyed
237,500
Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company, of which a total of 1,844,250 were subscribed for in 2014. A total of 388,750 shares have been subscribed for during the period 23 April 2015 and 5 May 2015 and 388,750 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 3887.50 funds received will be credited to the Company’s reserve for non-restricted equity. Due to share issues already made pursuant to the Stock Option Plan 2011, forfeitures and some of the instruments based on the plan having been left unallocated, a maximum of 2,195,000 shares may still be issued pursuant to the Stock Option Plan 2011.
The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:
Increase in number of outstanding shares 388,750
Total amount of
voting rights
452,990,234
Number of the
Company’s shares
held by the Group
2,977,940
Total number
of registered
shares
455,968,174
Turku, 6 May 2015
Biotie Therapies Corp.
Timo Veromaa, President and CEO
For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com
Help employers find you! Check out all the jobs and post your resume.
